drugset / Trial / NCT03606447

A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body When Administered Directly Into the Vein (IV)

NCT03606447

NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to measure how the radiolabelled test medicine \[14C\]-Uproleselan (GMI-1271) is taken up, broken down and removed from the body when given intravenously (into a vein) in a group of 6 males. 'Radiolabelled' means that the test medicine has a radioactive component which helps us to track where the drug is in the body. Blood urine and fecal samples will be collected at specific times throughout the study to measure amounts of the test medicine in the body.

Timeline

Start
2018-08-14
Primary completion
2018-09-13
Completion
2018-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Uproleselan Small molecule Intravenous

Indications

No indication recorded.